Abstract
The evaluation of preoperative cardiac risk in patients undergoing noncardiac surgery has been a challenging and important topic over the past 25 years. Given the growing prevalence of both coronary artery disease (CAD) and noncardiac surgical procedures in the United States,1 the preoperative evaluation for cardiac risk becomes more important. The medical parameters and clinical factors first reported by Goldman et al.2 have evolved into a more systematic approach and recently into American College of Cardiology/American Heart Association guidelines.3 Although controlled prospective or randomized clinical trials are lacking in this clinical area, there are many retrospective reports and a few metaanalyses that demonstrate the utility of nuclear cardiology testing in this evaluation process.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
American Heart Association. 2003 Heart and Stroke Statistical Update. Dallas: American Heart Association; 2003: 1 –46.
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med. 1977; 297: 845 –850.
Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery—executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). J Am Coll Cardiol. 2002; 39: 542 –553.
Califf RM, Armstrong PW, Carver JR, D’Agostino RB, Strauss WE. Task force 5: Stratification of patients into high, medium and low risk subgroups for purposes of risk factor management. J Am Coll Cardiol. 1996; 27: 1007 –1019.
Mukherjee D, Eagle KA. Perioperative cardiac assessment for noncardiac surgery: eight steps to the best possible outcome. Circulation. 2003; 107: 2771.
Detsky AS, Abrams HB, Forbath N, Scott JG, Hilliard JR. Cardiac assessment for patients undergoing noncardiac surgery: A multifactorial clinical risk index. Arch Intern Med. 1986; 146: 2131 –2134.
Eagle KA, Coley CM, Newell JB, et al. Combining clinical and thallium data optimizes preoperative assessment of cardiac risk before major vascular surgery. Ann Intern Med. 1989; 110: 859 –866.
Hlatky MA, Boineau RE, Higginbotham MB, et al. A brief self-administered questionnaire to determine functional capacity (the Duke Activity Status Index). Am J Cardiol. 1989; 64: 651 –654.
Froehlich JB, Karavite D, Russman PL, et al. American College of Cardiology/American Heart Association preoperative assessment guidelines reduce resource utilization before aortic surgery. J Vasc Surg. 2002; 36: 758 –763.
Kaluza GL, Joseph J, Lee JR, Raizner ME, Raizner AE. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol. 2000; 35: 1288 –1294.
Eagle KA, Rihal CS, Mickel MC, Holmes DR, Foster ED, Gersh BJ. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation. 1997; 96: 1882 –1887.
Gersh BJ, Rihal CS, Rooke TW, Ballard DJ. Evaluation and management of patients with both peripheral vascular and coronary artery disease. J Am Coll Cardiol. 1991;18:203–214.
Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients: a classification of 1000 coronary angiograms and results of surgical management. Ann Surg. 1984; 199: 223 –233.
Hollenberg M, Mangano DT, Browner WS, London MJ, Tubau JF, Tateo IM. Predictors of postoperative myocardial ischemia in patients undergoing noncardiac surgery. JAMA. 1992; 268: 205 –209.
Shaw LJ, Eagle KA, Gersh BJ, Miller DD. Meta-analysis of intravenous dipyridamolethallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. J Am Coll Cardiol. 1996; 27: 787 –798.
Mangano DT, London MJ, Tubau JF, et al. Study of perioperative ischemia research group: dipyridamole thallium-201 scintigraphy as a preoperative screening test: a reexamination of its predictive potential. Circulation. 1991; 84: 493 –502.
Baron JF, Mundler O, Bertrand M, et al. Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery. N Engl J Med.1994; 330: 663 –669.
Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999; 100: 1043 –1049.
Vanzetto G, Machecourt J, Blendea D, et al. Additive value of thallium single-photon emission computer tomography myocardial imaging for prediction of perioperative events in clinically selected high cardiac risk patients having abdominal aortic surgery. Am J Cardiol. 1996; 77: 143 –148.
Bartels C, Bechtel JF, Hossmann V, Horsch S. Cardiac risk stratification for high-risk vascular surgery. Circulation. 1997; 95: 2473 –2475.
Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med. 1999; 341: 1789 –1794.
Boersma E, Poldermans D, Bax JJ, et al. Predictors of cardiac events after major vascular surgery: Role of clinical characteristics, dobutamine, echocardiography, and beta-blocker therapy. JAMA. 2001; 285: 1865 –1873.
Poldermans D, Arnese M, Fioretti PM, et al. Sustained prognostic value of dobutamine stress echocardiography for late cardiac events after major noncardiac vascular surgery. Circulation. 1997; 95: 53 –58.
Wallace A, Layug B, Tateo I, et al. Prophylactic atenolol reduces postoperative myocardial ischemia. McSPI Research Group. Anesthesiology. 1998; 88: 7 –17.
Mangano DT, Layug EL, Wallace A, Tateo I. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996; 335: 1713 –1720.
Weinrauch LA, D’Elia JA, Healy RW, et al. Asymptomatic coronary artery disease: Angiography in diabetic patients before renal transplantation: Relations of findings to postoperative survival. Ann Intern Med. 1978; 88: 346 –348.
Heston TF, Norman DJ, Barry JM, Bennett WM, Wilson RA. Cardiac risk stratification in renal transplantation using a form of artificial intelligence. Am J Cardiol. 1997; 79: 415 –417.
Iqbal A, Gibbons RJ, McGoon MD, Steiroff S, Frohnert PT, Velosa JA. Noninvasive assessment of cardiac risk in insulin-dependent diabetic patients being evaluated for pancreatic transplantation using thallium-201 myocardial perfusion scintigraphy. Transplant Proc. 1991; 23: 1690 –1691.
Fattah AA, Kamal AM, Pancholy S, et al. Prognostic implications of normal exercise tomographic thallium images in patients with angiographic evidence of significant coronary artery disease. Am J Cardiol. 1994;74:769–771.
Kryzhanovski VA, Beller GA. Usefulness of preoperative noninvasive radionuclide testing for detecting coronary artery disease in candidates for liver transplantation. Am J Cardiol. 1997; 79: 986 –988.
Hendel RC, Chen MH, L’Italien GJ, et al. Sex differences in perioperative and long-term cardiac event-free survival in vascular surgery patients: an analysis of clinical and scintigraphic variables. Circulation. 1995;91:1044–1051.
Hertzer NR. Basic data concerning associated coronary artery disease in peripheral vascular patients. Ann Vasc Surg. 1987; 1: 616 –620.
L’Italien GJ, Cambria RP, Cutler BS, et al. Comparative early and late cardiac morbidity among patients requiring different vascular surgery procedures. J Vasc Surg.1995; 21: 935 –944.
Fleisher LA, Eagle KA, Shaffer T, Anderson GF. Perioperative-and long-term mortality rates after major vascular surgery: the relationship to preoperative testing in the Medicare population. Anesth Analg. 1999; 89: 849 –855.
Schueppert MT, Kresowik TF, Corry DC, et al. Selection of patients for cardiac evaluation before peripheral vascular operations. J Vasc Surg. 1996; 23: 802 –808.
Lette J, Waters D, Cerino M, Picard M, Champagne P, Lapointe J. Preoperative coronary artery disease risk stratification based on dipyridamole imaging and a simple three-step, three-segment model for patients undergoing noncardiac vascular surgery or major general surgery. Am J Cardiol. 1992; 69: 1553 –1558.
Emlein G, Villegas B, Dahlberg S, Leppo J. Left ventricular cavity size determined by preoperative dipyridamole thallium scintigraphy as a predictor of late cardiac events in vascular surgery patients. Am Heart J. 1996; 131: 907 –914.
Garcia EV, Bacharach SL, Mahmarian JJ, et al. Imaging guidelines for nuclear cardiology procedures. Part 1. J Nucl Cardiol. 1996;3:G1–G46.
White GH, Advani SM, Williams RA, Wilson SE. Cardiac risk index as a predictor of long-term survival after repair of abdominal aortic aneurysm. Am J Surg. 1988; 156: 103 –107.
Hendel RC, Leppo JA. The value of perioperative clinical indexes and dipyridamole thallium scintigraphy for the prediction of myocardial infarction and cardiac death in patients undergoing vascular surgery. J Nucl Cardiol. 1995; 2: 18 –225.
Massie MT, Rohrer MJ, Leppo JA, Cutler BS. Is coronary angiography necessary for vascular surgery patients who have positive results of dipyridamole thallium scans? J Vasc Surg. 1997; 25: 975 –983.
Pepine CJ, Allen HD, Bashore TM, et al. ACC/AHA guidelines for cardiac catheterization and cardiac catheterization laboratories. J Am Coll Cardiol. 1991; 18: 1149 –1182.
Kazmers A, Cerqueira MD, Zierler RE. Perioperative and late outcome in patients with left ventricular ejection fraction of 35% or less who require major vascular surgery. J Vasc Surg. 1988; 8: 307 –315.
Cutler BS, Hendel RC, Leppo JA. Dipyridamolethallium scintigraphy predicts perioperative and long-term survival after major vascular surgery. J Vasc Surg. 1992; 15: 972 –981.
Beller GA, Brown KA, Hendel RC, Shaw LJ, Williams KA. Unresolved issues in risk stratification: Chronic coronary artery disease including preoperative testing. J Nucl Cardiol. 1997; 4: 92 –95.
Licker M, Khatchatourian G, Schweizer A, Bednarkiewicz M, Tassaux D, Chevalley C. The impact of a cardioprotective protocol on the incidence of cardiac complications after aortic abdominal surgery. Anesth Analg. 2002; 95 (6): 1525 –1533.
Young AE, Sandberg GW, Couch NP. The reduction of mortality of abdominal aortic aneurysm resection. Am J Surg. 1977; 134: 585 –590.
Hertzer NR. Fatal myocardial infarction following lower extremity revascularization: two hundred seventy-three patients followed six to eleven postoperative years. Ann Surg. 1981; 193: 492 –498.
Cutler BS, Leppo JA. Dipyridamole thallium 201 scintigraphy to detect coronary artery disease before abdominal aortic surgery. J Vasc Surg. 1987; 5: 91 –100.
Raby KE, Goldman L, Creager MA, et al. Correlation between preoperative ischemia and major cardiac events after peripheral vascular surgery. N Engl J Med.1989; 321: 1296 –1300.
Younis LT, Aguirre F, Byers S, et al. Perioperative and long-term prognostic value of intravenous dipyridamole thallium scintigraphy in patients with peripheral vascular disease. Am Heart J. 1990; 119: 1287 –1292.
Hendel RC, Whitfield SS, Villegas BJ, Cutler BS, Leppo JA. Prediction of late cardiac events by dipyridamole thallium imaging in patients undergoing elective vascular surgery. Am J Cardiol. 1992; 70: 1243 –1249.
Taylor LM Jr, Yeager RA, Moneta GL, McConnell DB, Porter JM. The incidence of perioperative myocardial infarction in general vascular surgery. J Vasc Surg. 1991; 15: 52 –61.
Kresowik TF, Bower TR, Garner SA, et al. Dipyridamole thallium imaging in patients being considered for vascular procedures. Arch Surg. 1993; 128: 299 –302.
McFalls EO, Doliszny KM, Grund F, Chute E, Chesler E. Angina and persistent exercise thallium defects: Independent risk factors in elective vascular surgery. J Am Coll Cardiol. 1993; 21: 1347 –1352.
Bry JD, Belkin M, O’Donnell TF Jr, et al. An assessment of the positive predictive value and cost-effectiveness of dipyridamole myocardial scintigraphy in patients undergoing vascular surgery. J Vasc Surg. 1994; 19: 112 –124.
Seeger JM, Rosenthal GR, Self SB, Flynn TC, Limacher MC, Harward TR. Does routine stress-thallium cardiac scanning reduce postoperative cardiac complications? Ann Surg. 1994; 219: 654 –663.
Fleisher LA, Rosenbaum SH, Nelson AH, Jain D, Wackers FJ, Zaret BL. Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long term outcome. Anesthesiology. 1995; 83: 906 –917.
Boucher CA, Brewster DC, Darling C, Okada R, Strauss HW, Pohost GM. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. N Engl J Med. 1985; 312: 389 –394.
Fletcher JP, Antico VF, Gruenewald S, Kershaw LZ. Dipyridamole-thallium scan for screening of coronary artery disease prior to vascular surgery. J Cardiovasc Surg. 1988; 29: 666 –669.
Sachs RN, Tellier P, Larmignat P, et al. Assessment by dipyridamole-thallium-201 myocardial scintigraphy of coronary risk before peripheral vascular surgery. Surgery. 1988; 103: 584 –587.
Koutelou MG, Asimacopoulos PJ, Mahmarian JJ, Kimball KT, Verani MS. Preoperative risk stratification by adenosine thallium 201 single-photon emission computed tomography in patients undergoing vascular surgery. J Nucl Med. 1995; 2: 389 –394.
Marshall ES, Raichlen JS, Forman S, Heyrich GP, Keen WD, Weitz HH. Adenosine radionuclide perfusion imaging in the preoperative evaluation of patients undergoing peripheral vascular surgery. Am J Cardiol. 1995; 76: 817 –821.
Coley CM, Field TS, Abraham SA, Boucher CA, Eagle KA. Usefulness of dipyridamole-thallium scanning for preoperative evaluation of cardiac risk for nonvascular surgery. Am J Cardiol. 1992; 69: 1280 –1285.
Shaw L, Miller DD, Kong BA, et al. Determination of perioperative cardiac risk by adenosine thallium-201 myocardial imaging. Am Heart J. 1992; 124: 861 –869.
Brown KA, Rowen M. Extent of jeopardized viable myocardium determined by myocardial perfusion imaging best predicts perioperative cardiac events in patients undergoing noncardiac surgery. J Am Coll Cardiol. 1993; 21: 325 –330.
Younis L, Stratmann H, Takase B, Byers S, Chaitman BR, Miller DD. Preoperative clinical assessment and dipyridamole thallium-201 scintigraphy for prediction and prevention of cardiac events in patients having major noncardiovascular surgery and known or suspected coronary artery disease. Am J Cardiol. 1994; 74: 311 –317.
Stratmann HG,Younis LT, Wittry MD, Amato M, Mark AL, Miller DD. Dipyridamole technetium 99m sestamibi myocardial tomography for preoperative cardiac risk stratification before major or minor nonvascular surgery. Am Heart J. 1996; 132: 536 –541.
Van Damme H, Pierard L, Gillain D, Benoit T, Rigo P, Limet R. Cardiac risk assessment before vascular surgery: a prospective study comparing clinical evaluation, dobutamine stress echocardiography, and dobutamine 99mTc sestamibi tomoscintigraphy. Cardiovasc Surg. 1997;5:54–64.
Roger VL, Ballard DJ, Hallett JW Jr, Osmundson PJ, Puetz PA, Gersh BJ. Influence of coronary artery disease on morbidity and mortality after abdominal aortic aneurysmectomy: a population-based study, 1971–1987. J Am Coll Cardiol. 1989; 14: 1245 –1252.
Hertzer NR, Young JR, Beven EG, et al. Late results of coronary bypass in patients with infrarenal aortic aneurysms: the Cleveland Clinic study. Ann Surg. 1987; 205: 360 –367.
Lette J, Waters D, Champagne P, Picard M, Cerino M, Lapointe J. Prognostic implications of a negative dipyridamole-thallium scan: results in 360 patients. Am J Med. 1992;92:615–620.
Mangano DT, Browner WS, Hollenberg M, Li J, Tateo IM. Long-term cardiac prognosis following noncardiac surgery. JAMA. 1992;268:233–239.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Springer-Verlag New York, LLC
About this chapter
Cite this chapter
Leppo, J.A., Dahlberg, S. (2004). Risk Assessment Before Noncardiac Surgery. In: Vitola, J.V., Delbeke, D. (eds) Nuclear Cardiology and Correlative Imaging. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2038-1_11
Download citation
DOI: https://doi.org/10.1007/978-1-4612-2038-1_11
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-20707-0
Online ISBN: 978-1-4612-2038-1
eBook Packages: Springer Book Archive